Document Detail


Active immunisation against gastric inhibitory polypeptide (GIP) improves blood glucose control in an animal model of obesity-diabetes.
MedLine Citation:
PMID:  18937625     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Recent research suggests that long-term ablation of gastric inhibitory polypeptide (GIP) receptor signalling can reverse or prevent many of the metabolic abnormalities associated with dietary and genetically induced obesity-diabetes. The present study was designed to assess the sub-chronic effects of passive or active immunisation against GIP in ob/ob mice. Initial acute administration of GIP antibody together with oral glucose in ob/ob mice significantly increased the glycaemic excursion compared to controls (p<0.05). This was associated with a significant reduction (p<0.05) in the overall glucose-mediated insulin response. However, sub-chronic passive GIP immunisation was not associated with any changes in body weight, food intake or metabolic control. In contrast, active immunisation against GIP for 56 days in young ob/ob mice resulted in significantly (p<0.05) reduced circulating plasma glucose concentrations on day 56 compared to controls. There was a tendency for decreased circulating insulin in GIP immunised mice. The glycaemic response to intraperitoneal glucose was correspondingly improved (p<0.05) in mice immunised against GIP. Glucose-stimulated insulin levels were not significantly different from controls. Furthermore, insulin sensitivity was similar in mice immunised against GIP and respective controls. Overall, the results reveal that active, as opposed to passive, immunisation against GIP improves blood glucose control ob/ob mice.
Authors:
Nigel Irwin; Paula L McClean; Steven Patterson; Kerry Hunter; Peter R Flatt
Related Documents :
12490115 - Experimental study on a novel compound extracted from traditional chinese medicine for ...
15975995 - Roles of insulin receptor substrates in insulin-induced stimulation of renal proximal b...
19881255 - Regulation of soluble epoxide hydrolase (seh) in mice with diabetes: high glucose suppr...
19602585 - Pancreatic beta-cell overexpression of the glucagon receptor gene results in enhanced b...
18406765 - Pathogenesis of diabetic nephropathy.
12781675 - Carbohydrate and amino acid metabolism in tuber borchii mycelium during glucose utiliza...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Biological chemistry     Volume:  390     ISSN:  1431-6730     ISO Abbreviation:  Biol. Chem.     Publication Date:  2009 Jan 
Date Detail:
Created Date:  2008-12-17     Completed Date:  2009-03-12     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9700112     Medline TA:  Biol Chem     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  75-80     Citation Subset:  IM    
Affiliation:
School of Biomedical Sciences, University of Ulster, Coleraine BT52 1SA, Northern Ireland, UK. n.irwin@ulster.ac.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antibodies / immunology
Blood Glucose / metabolism*
Diabetes Mellitus / blood*,  metabolism
Disease Models, Animal*
Female
Gastric Inhibitory Polypeptide / antagonists & inhibitors*,  blood,  immunology*
Homeostasis / immunology
Humans
Immunization, Passive
Insulin / metabolism
Male
Mice
Obesity / blood*,  metabolism
Time Factors
Vaccination*
Chemical
Reg. No./Substance:
0/Antibodies; 0/Blood Glucose; 11061-68-0/Insulin; 59392-49-3/Gastric Inhibitory Polypeptide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Clindamycin phosphate/tretinoin gel formulation in the treatment of acne vulgaris.
Next Document:  Glycosphingolipids from bovine milk and milk fat globule membranes: a comparative study. Adhesion to...